LLY283, LM-5179
Iinkcukacha zeMveliso
Iithegi zeMveliso
Ubungakanani bePakethe | Ubukho | Ixabiso (USD) |
Igama leMchiza:
(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-[(R)-hydroxy(phenyl)methyl]oxolane-3,4-diol
Ikhowudi yoncumo:
O[C@H]1[C@H](N2C=CC3=C(N)N=CN=C32)O[C@H]([C@H](O)C4=CC=CC=C4) [C@H]1O
Ikhowudi ye-InChi:
InChI=1S/C17H18N4O4/c18-15-10-6-7-21(16(10)20-8-19-15)17-13(24)12(23)14(25-17)1 1(22)9-4-2-1-3-5-9/h1-8,11-14,17,22-24H,(H2,18,19,20)/t11-,12+,13- ,14-,17-/m1/s1
Isitshixo se-InChi:
WWOOWAHTEXIWBO-QFRSUPTLSA-N
Igama elingundoqo:
2040291-27-6;CAS:2040291-27-6;CAS:2040291-27-6;LLY-283;LLY 283;LLY283; LM-5179; LM 5179; LM5179;
Ukunyibilika:Inyibilika kwi-DMSO
Ugcino:Yomile, emnyama kunye ne-0 - 4 C kwixesha elifutshane (iintsuku ukuya kwiiveki) okanye -20 C ixesha elide (iinyanga ukuya kwiminyaka).
Inkcazo:
I-LY-283 iyiprotheni esebenzayo, ekhethiweyo, kunye ne-arginine methyltransferase 5 (PRMT5) inhibitor.
Ithagethi: PRMT5